Clinical trial
Podocyte Retinoids
NCT00098020 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00098020 |
|---|---|
| Title | Podocyte Retinoids |
| Official title | Retinoids for Podocyte Disease |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Collapsing Glomerulopathy, Glomerulosclerosis, Focal Segmental |
| Intervention type | Drug |
| Interventions | Isotretinoin |
| Enrollment | 12 |
| Start date | Nov 26, 2004 |
| Primary completion | Jun 27, 2016 |
| Completion | Jun 27, 2016 |
| First posted | Dec 2, 2004 |
| Last update posted | Dec 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: